Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 - - Reported highly positive 12-week primary endpoint results from Phase 2 ...

THE WOODLANDS, Texas, Nov. 12, 2025 (GLOBE NEWSWIRE) -- TWFG, Inc. ("TWFG”, the "Company” or "we”) (NASDAQ: TWFG), a ...

Lead candidate from mutant selective JAK2V617F JH2 inhibitor program advancing with IND filing expected in the first quarter of 2026Lead ...

Triumph (NYSE: TFIN), a financial and technology company focused on modernizing and simplifying freight transactions, announced that NFI, one of the largest third-party logistics companies in North ...

Q3 2025 Earnings Call Transcript November 11, 2025 Operator: Good day, and welcome to the Harrow Third Quarter 2025 Earnings ...

Positive randomized 3-month REMAIN-1 Midpoint Cohort data showed single Revitaprocedure maintained weight loss after GLP-1 discontinuation; ...

Q3 2025 Earnings Call November 12, 2025 5:00 PM ESTCompany ParticipantsLily Arteaga - Head of Investor RelationsMichael Tiedemann ...

Q3 2025 Earnings Call Transcript November 10, 2025 TeraWulf Inc. misses on earnings expectations. Reported EPS is $-1.13 EPS, ...

Good morning, ladies and gentlemen, and welcome to Gol Linhas Aéreas Conference Call to discuss the Third Quarter 2025 Results. This event is being broadcast via Zoom and can be accessed on the ...

The ultra-wealthy in Canada have amassed fortunes that most of us can barely fathom, building billion-dollar empires across ...

In the third quarter of 2025, tons sold totaled approximately 1,472,000, compared to 1,424,000 tons in the second quarter of 2025 and 1,189,000 tons in the third quarter of 2024, reflecting a 3% ...

Discover the best home-improvement products—lab-tested, expert-approved upgrades for kitchens, baths, and beyond from Good ...